Walgreens Specialty Pharmacy, LLC

Orlando, FL Part of Walgreen CO.

UEI
EBASWPM7BVB8
CAGE
5JN32
Primary NAICS
621999 All Other Miscellaneous Ambulatory Health Care Services
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
  • Walgreens Parent Walgreen CO. HRE3UMLEM2P5
    • Walgreens Specialty Pharmacy, LLC
SAM.gov registration date
Physical address
7003 Presidents Dr Suite 260, Orlando, FL 32809, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $39,729
FY2025 $274,791
FY2024 $100,739
FY2023 $475,880

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Veterans Affairs $39,729

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Grant subawards

Prime recipient Prime award Amount Awarded
Louisiana Department Of Health COVID Sample Testing NU50CK000532 $180,225
Louisiana Department Of Health COVID Sample Testing NU50CK000532 $86,850

Similar vendors

About the company

Walgreens Specialty Pharmacy, LLC is a for-profit subsidiary of the Walgreens retail pharmacy chain, registered in the System for Award Management since June 18, 2009, with headquarters in Orlando, Florida. As a specialized pharmaceutical provider, the company focuses on delivering complex and rare medications to federal healthcare facilities, particularly the Department of Veterans Affairs. Walgreens Specialty Pharmacy, LLC leverages its extensive pharmacy network and expertise to rapidly supply critical treatment options for veterans with serious and uncommon medical conditions, supporting the VA's mission to provide comprehensive healthcare services across the nation.

The federal contract award history for Walgreens Specialty Pharmacy, LLC demonstrates a sustained specialization in providing specialty pharmaceutical products to the Veterans Health Administration across multiple Veterans Integrated Service Networks. The company's primary product supplied through federal contracts is Jynarque (tolvaptan), a medication used to treat autosomal dominant polycystic kidney disease, with contract awards ranging from approximately $10,000 to $312,000 in individual purchase orders. Additional medications provided include Galafold (migalastat) and Cerdelga, representing the company's broader capability to supply rare and complex pharmaceutical treatments. Contracts have been awarded by Veterans Integrated Service Network 2, Veterans Integrated Service Network 6, Veterans Integrated Service Network 9, Veterans Integrated Service Network 20, and Veterans Integrated Service Network 21, with many awards designated as emergency procurement orders reflecting the critical nature of the medications involved. All identified awards are firm fixed-price purchase orders with no set-aside designations, indicating open competition among qualified vendors. Performance locations include multiple sites such as Pittsburgh, Pennsylvania; San Francisco, California; Belle Isle, Florida; and the New York Harbor region. Walgreens Specialty Pharmacy functions as the prime contractor on all awards reviewed, with no identified subcontractors. The company's contract activity demonstrates consistent engagement with the VA healthcare system from 2021 through December 2025, with particular emphasis on rapid delivery of specialized pharmaceuticals to support veteran healthcare needs.

Quick answers

Is Walgreens Specialty Pharmacy, LLC registered in SAM.gov?

Yes. Walgreens Specialty Pharmacy, LLC's SAM.gov registration is active through March 13, 2027.

How much has Walgreens Specialty Pharmacy, LLC received in federal contracts?

Federal contracts obligated $274,791 to Walgreens Specialty Pharmacy, LLC in fiscal year 2025 and $891,140 in fiscal years 2023 through 2027.

What is Walgreens Specialty Pharmacy, LLC's most recent federal award?

Walgreens Specialty Pharmacy, LLC's most recent federal contract award is Jynarque 45MG for new york harbor (36C24226P0262), from Veterans Integrated Service Network 2 (VHA), on December 30, 2025.

On GovTribe

See Walgreens Specialty Pharmacy, LLC's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors